(Date:11/24/2009)... York investment bank KTA Capital,s client Neuren ... mil convertible note private placement with a U.S...s arranged by KTA Capital as Neuren,s exclusive pl... New York (PRWEB) November 23, 2009 -- The inde...("KTA Capital") has announced that its c...
(Date:11/24/2009)... Sigma-Aldrich Corporati...AQ OMX conference on Tuesday, December 1st at 1:45...ies may listen via live audio broadcast over the I... a a ldrich.com/ . Users can click the "Webcas...-Aldrich: Sigma-Aldrich is a leading Life Scienc...
(Date:11/24/2009)..., Nov. 24 NeurogesX, Inc...cused on developing and commercializing novel pain...y DiTonno, President and Chief Executive Officer, ...affray Health Care Conference, to be held December...k, New York. ,, Mr. DiTonno and Stephen Ghigli...
(Date:11/24/2009)...y endpoint has been met for patients with advanced... QUEBEC CITY, Nov. 24 /PRNewswire-FirstCall/ - AEt... "Company"), a global biopharmaceutical company fo...ounced positive efficacy data from a Phase 2 study...ZS-108 (formerly AN-152), in patients with advance...
Breaking Biology Technology:KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4...tories, Inc.,(NYSE: FRX ), an international manuf...ill release its Fiscal 2009 Second Quarter financi...uesday, October 21, 2008. Later that,day, at 10:00...Dr. Lawrence,Olanoff, President and Chief Operatin...Finance and Chief Financial Officer, will discuss ...
...nt Effective in Preventing Thrombosis, .... 1 CeloNova BioSciences, Inc., today,announced t...ion of,Cardiology, Yokohama Hospital, Kanagawa, Ja...stem featuring NanoThin Polyzene(R)-F for treating...ring a live case symposium,at the Paris Cardiovasc...
...ldings, Inc.,(NYSE: ZMH ; SWX: ZMH) announced tod...rence call will be broadcast live over the Interne...ern Time. A news release,detailing the quarterly r...ning of the conference call., The live audio webc...s,website at http://investor.zimmer.com . It wil...
Other Biology Technology:Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2009 Second Quarter Earnings 2Physician to Implant the CATANIA(TM) Coronary Stent System With Polyzene(R)-F to Treat Chronic Total Occlusion During 'Live' Case at the Paris Cardiovascular Interventions Course (Francophone) 2008 2Physician to Implant the CATANIA(TM) Coronary Stent System With Polyzene(R)-F to Treat Chronic Total Occlusion During 'Live' Case at the Paris Cardiovascular Interventions Course (Francophone) 2008 3GeneAmplimer HIV-1 Control Reagents from Applied Biosystems
... Tissues are selected tissues from mouse, rat, and...araffin, sectioned and mounted onto slides. After ...tissue RNA localization by in situ hybridization. ... situ hybridization using both 35S-labeled and non...
Human Angiogenesis Array 1 Kit, Quantibody from Raybiotech, Inc.
Vybrant Multicolor Cell-Labeling Kit *DiO DiI DiD solutions 1 mL each* from Molecular Probes (Invitrogen)
Biology Products: